14 results on '"Pessoa, Ana Flávia Marçal"'
Search Results
2. Nutraceutical composition (yeast β-glucan, prebiotics, minerals, and silymarin) predicts improvement of sleep quality and metabolic parameters: A randomized pilot study
- Author
-
Santamarina, Aline Boveto, Nehmi Filho, Victor, Freitas, Jéssica Alves de, Silva, Bruna Fernanda Rio Branco da, Gusmão, Arianne Fagotti, Olivieri, Eloísa Helena Ribeiro, Souza, Erica de, Silva, Sabrina Lira da, Miranda, Danielle Araújo de, Demarque, Daniel Pecoraro, Oliveira, Eduarda dos Santos, Otoch, José Pinhata, and Pessoa, Ana Flávia Marçal
- Published
- 2024
- Full Text
- View/download PDF
3. Nutraceutical blends predict enhanced health via microbiota reshaping improving cytokines and life quality: a Brazilian double-blind randomized trial
- Author
-
Santamarina, Aline Boveto, de Freitas, Jéssica Alves, Franco, Lucas Augusto Moyses, Nehmi-Filho, Victor, Fonseca, Joyce Vanessa, Martins, Roberta Cristina, Turri, José Antônio, da Silva, Bruna Fernanda Rio Branco, Fugi, Beatriz Emi Itikawa, da Fonseca, Sumaia Sobral, Gusmão, Arianne Fagotti, Olivieri, Eloísa Helena Ribeiro, de Souza, Erica, Costa, Silvia, Sabino, Ester Cerdeira, Otoch, José Pinhata, and Pessoa, Ana Flávia Marçal
- Published
- 2024
- Full Text
- View/download PDF
4. Modulation of Small-Intestine Morphology in Mice by a Novel Supplement Containing Silybum marianum, Yeast β-Glucan, Prebiotics, and Minerals.
- Author
-
Nucci, Ricardo Aparecido Baptista, Nehmi-Filho, Victor Abou, Bastos, Marta Ferreira, de Freitas, Jéssica Alves, Otoch, José Pinhata, Pessoa, Ana Flávia Marçal, and Jacob-Filho, Wilson
- Subjects
BIOLOGICAL models ,T-test (Statistics) ,RESEARCH funding ,FLAVONOIDS ,PREBIOTICS ,CYTOCHEMISTRY ,QUANTITATIVE research ,DESCRIPTIVE statistics ,MICE ,EXPERIMENTAL design ,INTESTINAL absorption ,MILK thistle ,ANIMAL experimentation ,BETA-glucans ,MINERALS ,COMPARATIVE studies ,DATA analysis software ,STAINS & staining (Microscopy) ,SMALL intestine ,DIETARY supplements - Abstract
Silymarin, derived from Silybum marianum , has recently demonstrated its potential to improve health in conditions such as obesity and metabolic disturbances. Understanding the impact of nutraceuticals on intestinal morphology is crucial for developing supplements that promote a higher quality of life. Therefore, this study aimed to investigate the effects of nutraceutical supplementation with silymarin on the morphology of the small intestine. Sixty-day-old adult male C57BL/6 mice were divided into two groups: one receiving a standard chow (control) and the other receiving a novel silymarin supplement (experimental). Following the experimental period, the animals were euthanized, and fragments of the small intestine were collected for histochemical analysis using Masson's trichrome and periodic acid-Schiff with Alcian blue staining techniques. Our results revealed an increase in the number of villi per analyzed field in the experimental group, accompanied by a decrease in basic mucin, crypt depth, mucosal thickness, and villus spacing. In conclusion, this novel nutraceutical supplementation may play a crucial role in modulating small intestine morphology and enhancing absorption capacity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. A novel supplement with yeast β-glucan, prebiotic, minerals and Silybum marianum synergistically modulates metabolic and inflammatory pathways and improves steatosis in obese mice
- Author
-
Nehmi, Victor Abou, Murata, Gilson Masahiro, Moraes, Ruan Carlos Macêdo de, Lima, Gabriely Cristina Alves, De Miranda, Danielle Araujo, Radloff, Katrin, Costa, Raquel Galvão Figuerêdo, Jesus, Joyce de Cassia Rosa de, De Freitas, Jéssica Alves, Viana, Nayara Izabel, Pimenta, Ruan, Leite, Katia Ramos Moreira, Otoch, José Pinhata, and Pessoa, Ana Flávia Marçal
- Published
- 2021
- Full Text
- View/download PDF
6. Modulation of the gut microbiome and Firmicutes phylum reduction by a nutraceutical blend in the obesity mouse model and overweight humans: A double‐blind clinical trial.
- Author
-
Nehmi‐Filho, Victor, de Freitas, Jessica Alves, Franco, Lucas Augusto, Martins, Roberta Cristina, Turri, José Antônio Orellana, Santamarina, Aline Boveto, Fonseca, Joyce Vanessa da Silva, Sabino, Ester Cerdeira, Moraes, Bruna Carvalho, Souza, Erica, Murata, Gilson Masahiro, Costa, Silvia Figueiredo, Alcântara, Paulo Sérgio, Otoch, José Pinhata, and Pessoa, Ana Flávia Marçal
- Subjects
GUT microbiome ,FECAL contamination ,BIOMARKERS ,LABORATORY mice ,OBESITY ,ANIMAL disease models ,FUNCTIONAL foods - Abstract
Overweight and obesity are closely linked to gut dysbiosis/dysmetabolism and disrupted De‐Ritis ratio [aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio], which may contribute to chronic noncommunicable diseases onset. Concurrently, extensive research explores nutraceuticals, and health‐enhancing supplements, for disease prevention or treatment. Thus, sedentary overweight volunteers were double‐blind randomized into two groups: Novel Nutraceutical_(S) (without silymarin) and Novel Nutraceutical (with silymarin). Experimental formulations were orally administered twice daily over 180 consecutive days. We evaluated fecal gut microbiota, based on partial 16S rRNA sequences, biochemistry and endocrine markers, steatosis biomarker (AST/ALT ratio), and anthropometric parameters. Post‐supplementation, only the Novel Nutraceutical group reduced Clostridium clostridioforme (Firmicutes), Firmicutes/Bacteroidetes ratio (F/B ratio), and De‐Ritis ratio, while elevating Bacteroides caccae and Bacteroides uniformis (Bacteroidetes) in Brazilian sedentary overweight volunteers after 180 days. In summary, the results presented here allow us to suggest the gut microbiota as the action mechanism of the Novel Nutraceutical promoting metabolic hepatic recovery in obesity/overweight non‐drug interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. VITAMINA E E NANOPARTÍCULAS LIPÍDICAS SÓLIDAS (NLSS): PARCEIRAS NA CICATRIZAÇÃO DA FERIDA DIABÉTICA.
- Author
-
Pessoa, Ana Flávia Marçal, Amaral, Bruna Karla do, Blanck, Maria da Conceição Baldini Benevides, Silva, Silvia Sousa da, Pedrosa, Adelso Aparecido, Martins, Camila Safranski, and Otoch, José Pinhata
- Published
- 2021
- Full Text
- View/download PDF
8. VITAMIN E AND SOLID LIPID NANOPARTICLES (SLNS): PARTNERS IN DIABETIC WOUND HEALING.
- Author
-
Pessoa, Ana Flávia Marçal, Amaral, Bruna Karla do, Blanck, Maria da Conceição Baldini Benevides, Silva, Silvia Sousa da, Technician, Pedrosa, Adelso Aparecido, Martins, Camila Safranski, and Otoch, José Pinhata
- Published
- 2021
- Full Text
- View/download PDF
9. Topical Insulin Modulates Inflammatory and Proliferative Phases of Burn-Wound Healing in Diabetes-Induced Rats.
- Author
-
Azevedo, Flávia Figueiredo, Moreira, Gabriela Virgínia, Teixeira, Caio Jordão, Pessoa, Ana Flávia Marçal, Alves, Michele Joana, Liberti, Edson Aparecido, Carvalho, Carla Roberta Oliveira, Araújo, Eliana Pereira, Saad, Mário José Abdala, and Lima, Maria Helena Melo
- Subjects
CELL proliferation ,ANIMAL experimentation ,BURNS & scalds ,DIABETES ,ENZYME-linked immunosorbent assay ,INFLAMMATION ,INSULIN ,INTERLEUKINS ,RATS ,RESEARCH funding ,STATISTICAL sampling ,STAINS & staining (Microscopy) ,T-test (Statistics) ,CUTANEOUS therapeutics ,TUMOR necrosis factors ,UREA ,WOUND healing ,VASCULAR endothelial growth factors ,MANN Whitney U Test ,ONE-way analysis of variance - Abstract
The healing time of burn wounds depends on surface area and depth of the burn and associated comorbidities. Diabetes mellitus (DM) causes delays in the healing process by extending the inflammatory phase. Treatment with topical insulin can improve the inflammatory phase, restore metabolic dysregulation, and modulate impaired cellular signaling in burn wounds. The objective of this study was to evaluate markers of the inflammatory and proliferative phases of second-degree burns after topical insulin treatment in diabetic rats. Type I DM was induced with streptozotocin in male Wistar rats. The animals' backs were shaved and subjected to thermal burning. Rats were randomized into two groups: control diabetic (DC) and insulin diabetic (DI). At Days 7 and 14 postburn, rats were euthanized, and wound-tissue sections were evaluated by hematoxylin and eosin, Weigert, and Verhöeff staining, immunohistochemistry-paraffin, and enzyme-linked immunosorbent assay. A significant increase in reepithelialization was seen on Days 7 and 14 in DI versus DC rats. On Day 7, interleukin (IL)-1β, IL-6, monocyte chemotactic protein (MCP)-1, and F4/80 expression were increased in DI versus DC rats. On Day 14, MCP-1 expression was decreased and F4/80 increased in DI versus DC rats. On Days 7 and 14, Ki-67, transforming growth factor-β1, vascular endothelial growth factor expression, and formation of elastic fibers were increased in DI versus DC rats. Topical insulin modulates burn-wound healing in diabetic animals by balancing inflammation and promoting angiogenesis and formation of elastic fibers. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Oral administration of antioxidants improves skin wound healing in diabetic mice.
- Author
-
Pessoa, Ana Flávia Marçal, Florim, Juliana Costa, Rodrigues, Hosana Gomes, Andrade‐Oliveira, Vinicius, Teixeira, Simone A., Vitzel, Kaio Fernando, Curi, Rui, Saraiva Câmara, Niels Olsen, Muscará, Marcelo N., Lamers, Marcelo Lazzaron, and Santos, Marinilce Fagundes
- Subjects
- *
BLOOD sugar analysis , *DIABETES complications , *ANALYSIS of variance , *ANIMAL experimentation , *ANTIOXIDANTS , *BIOLOGICAL models , *BODY weight , *CYTOKINES , *DIABETES , *DIETARY supplements , *ENZYME-linked immunosorbent assay , *FLOW cytometry , *HYPERGLYCEMIA , *INFLAMMATION , *LIPID peroxidation (Biology) , *MICE , *ORAL drug administration , *PHOTOGRAPHY , *PROBABILITY theory , *RESEARCH funding , *VITAMIN C , *VITAMIN E , *WOUND healing , *TRAUMATOLOGY diagnosis , *PHENOTYPES , *OXIDATIVE stress , *CHRONIC wounds & injuries , *DESCRIPTIVE statistics , *THERAPEUTICS - Abstract
Oxidative stress aggravates several long-term complications in diabetes mellitus. We evaluated the effectiveness of the oral administration of antioxidants (vitamins E and C, 40 and 100 mg/kg b.w., respectively) on skin wound healing acceleration in alloxan-induced diabetic mice. Mice were wounded 30 days after the induction of diabetes. Antioxidants were effective in preventing oxidative stress, as assessed by TBARS. The enzymes catalase, glutathione reductase, glutathione peroxidase, and superoxide dismutase were increased in diabetics on the 3rd day post-wounding; catalase and glutathione peroxidase remained still augmented in diabetics after 14th day postwounding, and the treatment with vitamins restored their activities to control. After 3 days, diabetic mice showed lower infiltration of inflammatory cells (including CD11b+ and Ly6G+ cells) and reduced levels of KC, TNF-α, IL-1β, and IL-12 p40 when compared with control mice. The treatment restored cytokine levels. After 14 days, diabetic mice showed late wound closure, persistent inflammation and delayed reepithelialization, accompanied by an increase in MIG+/CD206− macrophages whereas CD206+/MIG− macrophages were decreased. Cytokines IL-12p40, TNF-α, IL-1β, and KC were increased and normal levels were restored after treatment with antioxidants. These results suggest that oxidative stress plays a major role in diabetic wound healing impairment and the oral administration of antioxidants improves healing by modulating inflammation and the antioxidant system with no effect on glycemia. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
11. The Symbiotic Effect of a New Nutraceutical with Yeast β-Glucan, Prebiotics, Minerals, and Silybum marianum (Silymarin) for Recovering Metabolic Homeostasis via Pgc-1α , Il-6 , and Il-10 Gene Expression in a Type-2 Diabetes Obesity Model.
- Author
-
Santamarina, Aline Boveto, Moraes, Ruan Carlos Macêdo, Nehmi Filho, Victor, Murata, Gilson Masahiro, de Freitas, Jéssica Alves, de Miranda, Danielle Araujo, Cerqueira, Anderson Romério Azevedo, Costa, Soraia Katia Pereira, Ferreira, Ana Flávia Fernandes, Britto, Luiz Roberto, de Camargo, Juliana Alves, Rodrigues de Oliveira, Daniela, de Jesus, Flavia Neto, Otoch, José Pinhata, and Pessoa, Ana Flávia Marçal
- Subjects
TYPE 2 diabetes ,HOMEOSTASIS ,GENE expression ,MILK thistle ,INTERLEUKIN-6 ,PREBIOTICS ,BETA-glucans - Abstract
The use of natural products and derivatives for the prevention and control of non-communicable chronic diseases, such as type-2 diabetes (T2D), obesity, and hepatic steatosis is a way to achieve homeostasis through different metabolic pathways. Thus, male C57BL/6 mice were divided into the following groups: high-fat diet (HFD) vehicle, HFD + Supplemented, HFD + Supplemented_S, and isolated compounds. The vehicle and experimental formulations were administered orally by gavage once a day over the four weeks of the diet (28 consecutive days). We evaluated the energy homeostasis, cytokines, and mitochondrial gene expression in these groups of mice. After four weeks of supplementation, only the new nutraceutical group (HFD + Supplemented) experienced reduced fasting glycemia, insulin, HOMA index, HOMA-β, dyslipidemia, ectopic fat deposition, and hepatic fibrosis levels. Additionally, the PPARγ coactivator 1 α (Pgc-1α), interleukin-6 (Il-6), and interleukin-10 (Il-10) gene expression were augmented, while hepatic steatosis decreased and liver parenchyma was recovered. The glutathione-S-transferase activity status was found to be modulated by the supplement. We discovered that the new nutraceutical was able to improve insulin resistance and hepatic steatosis mainly by regulating IL-6, IL-10, and Pgc-1α gene expression. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Effect of thyroid hormones on rat exocrine pancreas morphology and function.
- Author
-
Goulart-Silva, Francemilson, Pessoa, Ana Flávia Marçal, Costa, Raquel Galvão Figueredo, Bargi-Souza, Paula, Santos, Marinilce Fagundes, and Nunes, Maria Tereza
- Subjects
- *
DIGESTIVE enzymes , *PANCREATIC acinar cells , *THYROID hormones , *PANCREAS , *MORPHOLOGY , *CELL morphology , *PANCREATIC enzymes - Abstract
The influence of thyroid hormones on exocrine pancreas function is poorly understood, and limited to the postnatal development period. Here, we evaluated the effects of hypo- and hyperthyroidism on the morphology and enzyme content of this tissue. To induce hypothyroidism male Wistar rats were subjected to a thyroidectomy (Tx) or sham operated (SO). After 40 days, some of the Tx and SO rats were treated with T3 for 7 days. Following euthanization, the pancreas was removed and evaluated for morphology, as well as amylase, lipase and trypsin content, using histological and immunoreactive techniques analyses, respectively. Serum amylase levels were also evaluated. The pancreatic acinar cells of Tx rats were smaller, exhibited reduced Haematoxyllin stained areas, and contained lower amylase and lipase levels, indicative of low cell activity. Tx rats also presented higher collagen levels, and high trypsin content in pancreatic extracts. Interestingly, T3 administration reversed the observed acinar cell alterations and restored pancreatic enzyme content, by augmenting amylase and lipase and attenuating trypsin levels, but failed to change collagen content. Increased levels of lipase and decreased trypsin were also observed in T3-treated SO rats. Thyroid hormones play an important role in acinar cell morphology and function. In the hypothyroid state there is a decrease in pancreatic enzyme levels that is restored with T3 treatment. In addition to participating in insulin sensitivity and glycemic control, THs also modulate enzyme expression and activity in the exocrine pancreas, consequently, delivering metabolic substrates to specific organs and tissues. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Role of Nutritional Supplements on Gut-Muscle Axis Across Age: a Mini-Review.
- Author
-
Nucci RAB, Filho VAN, Jacob-Filho W, Otoch JP, and Pessoa AFM
- Subjects
- Humans, Muscle, Skeletal metabolism, Aging physiology, Dietary Supplements, Inflammation pathology, Sarcopenia etiology, Insulin Resistance
- Abstract
Sarcopenia is a progressive skeletal muscle disorder associated with aging, resulting in loss of muscle mass and function. It has been linked to inflammation, oxidative stress, insulin resistance, hormonal changes (i.e. alterations in the levels or activity of hormones which can occur due to a variety of factors, including aging, stress, disease, medication, and environmental factors), and impaired muscle satellite cell activation. The gut microbiome is also essential for muscle health, and supplements such as probiotics, prebiotics, protein, creatine, and betaalanine can support muscle growth and function while also promoting gut health. Chronic low-grade inflammation is a leading cause of sarcopenia, which can activate signaling pathways that lead to muscle wasting and reduce muscle protein synthesis. Insulin resistance, hormonal changes, and impaired muscle satellite cell activation contribute to sarcopenia, and high levels of fat mass also play a role in the pathogenesis of sarcopenia. Resistance exercise and dietary supplementation have been shown to be effective treatments for sarcopenia. In addition, a combination of resistance exercise and supplementation has been shown to have a more significant beneficial effect on anthropometric and muscle function parameters, leading to a decrease in sarcopenic state. Thus, understanding the relationship between the gut microbiome and muscle metabolism is crucial for developing new treatments for sarcopenia across age groups., Competing Interests: The authors have no conflicts of interest to declare., (© Copyright by the Author(s). Published by Cell Physiol Biochem Press.)
- Published
- 2023
- Full Text
- View/download PDF
14. Novel nutraceutical supplements with yeast β-glucan, prebiotics, minerals, and Silybum marianum (silymarin) ameliorate obesity-related metabolic and clinical parameters: A double-blind randomized trial.
- Author
-
Nehmi-Filho V, Santamarina AB, de Freitas JA, Trarbach EB, de Oliveira DR, Palace-Berl F, de Souza E, de Miranda DA, Escamilla-Garcia A, Otoch JP, and Pessoa AFM
- Subjects
- Male, Adult, Humans, Female, Saccharomyces cerevisiae, Silybum marianum, Prebiotics, Obesity complications, Dietary Supplements, Minerals, Biomarkers, Silymarin therapeutic use, Non-alcoholic Fatty Liver Disease drug therapy, Diabetes Mellitus, Type 2 therapy, Diabetes Mellitus, Type 2 complications, beta-Glucans therapeutic use
- Abstract
Purpose: It is known that obesity has a multifactorial etiology that involves genetic and environmental factors. The WHO estimates the worldwide prevalence of 1.9 billion overweight adults and more than 650 million people with obesity. These alarming data highlight the high and growing prevalence of obesity and represent a risk factor for the development and aggravation of other chronic diseases, such as nonalcoholic fatty liver disease (NAFLD) that is frequently considered the hepatic outcome of type 2 diabetes. The use of non-pharmacological therapies such as food supplements, nutraceuticals, and natural integrative therapies has grown as an alternative tool for obesity-related diseases compared to conventional medications. However, it is a still little explored research field and lacks scientific evidence of therapeutic effectiveness. Considering this, the aim is to evaluate whether a new nutraceutical supplement composition can improve and supply essential mineral nutrients, providing an improvement of obesity-related metabolic and endocrine parameters., Methods: Sedentary volunteers (women and men) with body mass index (BMI) ≤34.9 kg/m
2 were divided into two groups: Novel Nutraceutical Supplement_(S) (n = 30) and Novel Nutraceutical Supplement (n = 29), differing in the absence (S) or presence of silymarin, respectively. Volunteers were instructed to take two capsules in the morning and two capsules in the evening. No nutritional intervention was performed during the study period. The data (anthropometrics and anamneses) and harvest blood (biochemistry and hormonal exams) were collected at three different time points: baseline time [day 0 (T0)], day 90 (T90), and day 180 (T180) post-supplementation., Results: In the anthropometric analysis, the waist circumference in middle abdomen (WC-mid) and waist circumference in iliac crest (WC-IC) were reduced. Also, the waist-to-height ratio (WHt R) and waist-to-hip ratio (WHR) seem to slightly decrease alongside the supplementation period with both nutraceutical supplements tested as well as transaminase enzyme ratio [aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio (AAR)], a known as a biomarker of NAFLD, and endocrine hormones cortisol and thyroid-stimulating hormone (TSH) at 90 and 180 days post-supplementation., Conclusions: In a condition associated with sedentary and no nutritional intervention, the new nutraceutical supplement composition demonstrated the ability to be a strong and newfangled tool to improve important biomarkers associated with obesity and its comorbidities., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Nehmi-Filho, Santamarina, de Freitas, Trarbach, de Oliveira, Palace-Berl, de Souza, de Miranda, Escamilla-Garcia, Otoch and Pessoa.)- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.